RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Organ-On-A-Chip Technology: An In-depth Review of Recent Advancements and Future of Whole Body-on-chip

        Rishab Driver,Shweta Mishra 한국바이오칩학회 2023 BioChip Journal Vol.17 No.1

        One of the leading challenges facing the pharmaceutical industry today is the ‘high attrition rate problem’, with a large number of drug candidates being abandoned before reaching the clinical stage. The high failure rate is not only costly for the pharmaceutical industry but also hinders the access of patients to better treatment options. This ever-widening gap can be attributed to the current in-vitro and animal testing techniques for predicting human responses to drug candidates. Twodimensional (2D) in-vitro cell culture fails to recapitulate key physical and biochemical cues while phylogenetic differences between animal models and humans in key physiological systems make data generated by these platforms unreliable. There have been several solutions proposed but one that has been gaining a lot of prominence are microfluidic-based microsystems able to mimic organs, called ‘Organ-On-A-Chip’ devices and is built upon the principles of microfluidics, material science, and cell biology. Here we delve into the ongoing research involving this platform demonstrating its key strengths and the application of this technology in several key stages of drug discovery such as target identification and high throughput screening. We also discuss the potential, future, and key obstacles that lie in the universal adoption of this technology.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼